Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

NICE approves lung cancer drug

  • Comment

NICE has issued final guidance on the on the use of pemetrexed disodium (Alimta) for the treatment of malignant pleural mesothelioma, an asbestos-induced lung cancer.

The institute recommend that the drug be made available on the NHS for all patients who are considered to have advanced disease, and for whom surgical intervention is not deemed appropriate.

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.